Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03510975
Other study ID # 014
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 1, 2015
Est. completion date March 1, 2018

Study information

Verified date April 2018
Source Ankara Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is aimed to demonstrate the benefits of newly formed written check-list of behavioral instructions and investigate its effects on parent's awareness, consciousness and motivation toward MNE.

The parents with children who complain of bed-wetting 3 or more nights per week for at last 14 days, they was randomly divided into three groups. The parents in Group I were instructed only a verbal behavioral therapy, the parents in Group II were instructed a behavioral therapy with a written formed check-list for parents to fulfill and the children in Group III will received desmopressin treatment plus verbal behavioral therapy. All participants were analysed the compliance and response rate of treatment over time period of 8 week.


Description:

Monosymptomatic Nocturnal Enuresis (MNE) is defined as involuntarily nighttime bed-wetting after the age of 5 years without any other lower urinary tract symptoms and without a history of bladder dysfunction. MNE can lead to developmental and psychosocial problems on child and negative impact of the family life. It has been recommended that consisting of collaboration with children and their parents is very crucial point to tackle this disturbing condition.

Behavioral therapy can be effective and these should be first-line treatment for MNE on the basis of the attitude of the child and parents. The behavioral therapy is composed of a lot of verbal recommendations including urination before going to sleep at night, a monitorisation daily fluid intake, a restriction of fluid volume before bedtime, rewards for dry nights, etc. However, we have noticed that these instructions have not been documented as a written list yet. We have analysed the literature and composed several recommendations were formed as a written check-list for parents to instruct.

In this present study, we aimed to investigate the efficiency of check-list that are newly formed by a number of written behavioral instructions and demonstrate whether this rises awareness, consciousness and motivation of child's parents toward MNE.

This study was conducted as a prospective randomized study at the Urology Department, Ankara Training and Research Hospital, Medical Science University, Ankara, Turkey Of ninety six children and their parents, seventy-five were randomly selected from the Urology outpatient clinic complaining of MNE. They were divided into three groups according to the therapy which were defined by the investigators before recruitment. Twenty-five children and their parents were instructed only a verbal behavioral therapy, 25 were instructed a behavioral therapy with a written check-list form and 25 children received desmopressin treatment plus verbal behavioral therapy were randomly included in the study. Each participants in this study was recorded medical history, demographic data including age of children and parents, number of children, educational and economic status of parents, wet nights. Economic status of family was defined by the hunger and the poverty limits from data of Turkish Statistical Institute All children were done detailed physical examination to rule out abnormal physical development, presence of genitourinary or neurological diseases. Urine analysis, serum creatinine, blood urine nitrogen, sodium, potassium, complete blood count, ultrasonography or plain X ray if necessary were measured.

The parents in Group I were received verbal behavioral instruction. 25 parents in Group II were instructed to fulfill a check-list that were composed of written instructions during a 8 week period. Also children had to register their wet nights via daily voiding diary. 25 children in Group III were received desmopressin melt form 120 μg (Minirin, Ferring International center, Switzerland) once daily before going to bed for 2 months plus verbal behavioral instructions. Details and instructions about the drug and its use were given to the all children and their parents. All participants were checked every 2 weeks to control compliance rate of behavioral therapy (written or verbal) or medical treatment and analyse the response of the children with daily voiding diary.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date March 1, 2018
Est. primary completion date December 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 15 Years
Eligibility Inclusion Criteria:

- monosymptomatic nocturnal enuresis

- bed-wetting frequency of 3 or more nights per week for at last 14 days

Exclusion Criteria:

- active urinary tract infection

- non-monosymptomatic nocturnal enuresis

- endocrinologic disease like diabetes mellitus or diabetes insipidus which can cause polyuria

- presence or history of renal disease

- hypertension

- genitourinary abnormality

- neurological or psychological disease

- previous medical or alarm therapy for nocturnal enuresis.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
desmopressin melt form 120 µg
desmopressin melt form 120 µg (Minirin, Ferring International center, Switzerland) once daily before going to bed
Behavioral:
Verbal behavioral therapy
Verbal behavioral therapy includes reward system, restriction excessive fluid intake, lifting and waking after sleep to urinate, keeping daily voiding diary
Behavioral therapy with written check-list
Behavioral therapy with written check-list includes reward system, restriction excessive fluid intake, lifting and waking after sleep to urinate, keeping daily voiding diary, ensuring optimal posture to facilitate good bladder function and bowel movements, avoding holding urine, encouring healthy diet

Locations

Country Name City State
Turkey Ankara Training and Research Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Caldwell PH, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013 Jul 19;(7):CD003637. doi: 10.1002/14651858.CD003637.pub3. Review. — View Citation

Haid B, Tekgül S. Primary and Secondary Enuresis: Pathophysiology, Diagnosis, and Treatment. Eur Urol Focus. 2017 Apr;3(2-3):198-206. doi: 10.1016/j.euf.2017.08.010. Epub 2017 Sep 6. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary dry nights dry nights were checked by daily voiding diary 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT04191863 - Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
Recruiting NCT03199508 - Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children N/A
Enrolling by invitation NCT05710718 - PureWick™ France and U.S. At-Home Pilot Study N/A
Recruiting NCT06135311 - Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children N/A
Completed NCT03047720 - Scheduled Awakenings for the Treatment of Nocturnal Enuresis N/A
Recruiting NCT05617664 - Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis N/A
Completed NCT02328092 - A Double-blind Randomized Clinical Trial on the Efficacy of Magnetic Sacral Roots Stimulation for the Treatment of NE N/A
Completed NCT02068560 - The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion N/A
Withdrawn NCT02337413 - Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis Phase 4
Completed NCT01368913 - MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis N/A
Terminated NCT04420585 - Desmopressin for Bedwetting in Children With SCD Phase 4
Completed NCT02538302 - Minirin Versus Oxybutynin for Nocturnal Enuresis in Children Phase 3
Recruiting NCT04676139 - The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children Phase 3
Completed NCT03812094 - Basic Bladder Advice and Alarm Therapy in Nocturnal Enuresis N/A
Recruiting NCT03477812 - Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study
Completed NCT02178826 - Nocturnal Enuresis and Rapid Maxillary Expansion N/A
Recruiting NCT01575678 - The Effect of Melatonin on Nocturnal Enuresis Phase 2
Completed NCT01078753 - Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis Phase 3
Recruiting NCT04313192 - TENS Treatment for Bedwetting N/A